UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 60 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,000 | -60.0% | 5,999 | -39.1% | 0.00% | – |
| Q2 2021 | $45,000 | -74.7% | 9,858 | -67.0% | 0.00% | – |
| Q1 2021 | $178,000 | +191.8% | 29,841 | +155.8% | 0.00% | – |
| Q4 2020 | $61,000 | +10.9% | 11,668 | -27.7% | 0.00% | – |
| Q3 2020 | $55,000 | -65.6% | 16,143 | -12.9% | 0.00% | – |
| Q2 2020 | $160,000 | +185.7% | 18,531 | +95.0% | 0.00% | – |
| Q1 2020 | $56,000 | -73.6% | 9,505 | -67.6% | 0.00% | – |
| Q4 2019 | $212,000 | +149.4% | 29,345 | +110.0% | 0.00% | – |
| Q3 2019 | $85,000 | -65.6% | 13,971 | -46.3% | 0.00% | – |
| Q2 2019 | $247,000 | +42.0% | 26,021 | +21.4% | 0.00% | – |
| Q1 2019 | $174,000 | +656.5% | 21,434 | +1431.0% | 0.00% | – |
| Q4 2018 | $23,000 | -34.3% | 1,400 | -34.3% | 0.00% | – |
| Q3 2018 | $35,000 | +45.8% | 2,132 | +36.0% | 0.00% | – |
| Q2 2018 | $24,000 | – | 1,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $9,117,000 | 23.05% |
| Invus Financial Advisors, LLC | 2,189,998 | $12,702,000 | 6.24% |
| Leap Investments LP | 13,400 | $78,000 | 0.11% |
| Moloney Securities Asset Management, LLC | 51,950 | $301,000 | 0.11% |
| Verity Asset Management, Inc. | 14,748 | $86,000 | 0.11% |
| Virtus ETF Advisers LLC | 43,010 | $249,000 | 0.10% |
| Investors Financial Group, LLC | 15,850 | $92,000 | 0.09% |
| SUNFLOWER BANK, NA WEALTH MANAGEMENT | 20,000 | $116,000 | 0.04% |
| Baillie Gifford | 3,803,014 | $22,057,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,047 | $1,827,000 | 0.02% |